🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Nath Bio-Genes (India) Limited NATHBIOGEN NSEINFRA

Basic Materials · Agricultural Inputs · India
https://nathbiogenes.com
Company Profile ↓
₹162.15
-27.57% 1Y
Mkt Cap₹308.15 Cr
P/E7.73
P/B0.54
Div. Yield1.21%
52W High₹227.04
52W Low₹129.02
Book Value₹358.06
EPS (TTM)₹20.98

Company Overview

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jowar; and seeds for vegetables comprising chilli, okra, tomato, bitter gourd, and cucumber. It also provides crop protection supplements under the Win-chi-Win, WinGoli, and WinPro Granules brands; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX brand names. The company was founded in 1979 and is based in Mumbai, India.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 13.9% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 7.7, below the sector median of 27.4.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.20.

Recent Developments

  • Mar 2026 Revenue of ₹445.10 Cr (+22.0% YoY); net profit ₹41.63 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +22.0%, earnings +7.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 13.9%, profit CAGR 5.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:13.88%
1 Year:21.98%

Compounded Profit Growth

5 Years:5.94%
1 Year:7.85%

Stock Price Performance

1 Year:-27.57%
6 Months:+6.17%
3 Months:-7.21%
1 Month:-4.06%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 34% of range
₹129.02 ₹227.04
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)42.80 · Neutral
Price Performance
1M-4.06%
3M-7.21%
6M+6.17%
1Y-27.57%
Valuation vs Sector

P/E of 7.73 is below the sector median of 27.45 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 13.9% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading 28.6% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
7.73
Industry PE
27.45
Forward P/E est.
7.17
PEG Ratio
-
Book Value
₹358.06
Price to Book
0.54
P/S
0.71
EV/EBITDA
8.23
Dividend Yield
1.21%

Growth (CAGR)

Revenue 5Y
13.88%
Profit 5Y
5.94%
Revenue (YoY)
21.98%
Earnings (YoY)
7.85%

Profitability & Returns

ROCE
8.86%
ROE
6.12%
ROA
3.79%
Profit Margin
9.35%
Op Margin
10.89%
Gross Margin
54.73%
EPS (Latest Qtr)
₹-0.79
EPS (TTM)
₹20.98

Balance Sheet & Liquidity

Debt/Equity
0.20
Quick Ratio
0.83
Current Ratio
1.97
Debt
₹138.50 Cr
Total Assets
₹1,097.42 Cr
Current Assets
₹778.86 Cr
Working Capital
₹384.17 Cr

Ownership

Promoter Holding
61.70%
Chg in Prom Hold
16.11%
FII / Inst Holding
0.00%
Chg in FII Hold
-0.23%

Financial Snapshot

Enterprise Value
₹308.15 Cr
Total Revenue (TTM)
₹445.10 Cr
EBITDA
₹66.26 Cr
Free Cash Flow
₹-15.58 Cr
Operating Cash Flow
₹-12.57 Cr
Shares Outstanding
₹1.90 Cr
Gross Margin
54.73%
Payout Ratio
9.53%

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 NATHBIOGEN Nath Bio-Genes (India) Limited NSEINFRA 162.15 7.73 ₹308.15 Cr 1.21% 8.86% 6.12% 13.88% 5.94%
2 ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA 11,659.00 56.84 ₹3.44 L Cr 0.66% 11.90% 10.66% 12.40% 17.26%
3 JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA 1,244.70 86.92 ₹3.04 L Cr 0.57% 18.75% 22.30% 3.61% 75.28%
4 ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA 2,675.50 59.31 ₹2.57 L Cr 1.03% 24.41% 20.24% 1.10% 1.75%
5 TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA 187.67 21.70 ₹2.34 L Cr 2.09% 11.32% 10.56% -1.59% 7.21%
6 HINDZINC Hindustan Zinc Limited NSEINFRA 532.50 16.26 ₹2.25 L Cr 3.91% 61.97% 61.13% 5.61% 9.58%
7 HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA 963.55 16.01 ₹2.17 L Cr 0.52% 9.42% 9.80% 7.10% 9.87%
8 GRASIM Grasim Industries Limited NIFTY50NSEINFRA 3,133.10 56.45 ₹2.13 L Cr 0.31% 4.00% 4.80% 14.63% -10.06%
9 VAML Vedanta Aluminium Metal Limited NSEINFRA 452.95 inf ₹1.77 L Cr 0.00% 41.97% 49.39% - -46.32%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 44.99 Cr235.28 Cr22.57 Cr31.74 Cr43.04 Cr243.88 Cr32.19 Cr36.87 Cr51.97 Cr283.70 Cr43.85 Cr65.96 Cr51.59 Cr
Cost of Revenue --------17.68 Cr139.82 Cr17.11 Cr28.78 Cr15.80 Cr
Gross Profit --------34.29 Cr143.88 Cr26.74 Cr37.18 Cr35.79 Cr
Operating Expenses 41.06 Cr198.26 Cr17.58 Cr26.09 Cr39.11 Cr207.34 Cr27.38 Cr28.83 Cr35.22 Cr106.57 Cr21.63 Cr34.58 Cr32.34 Cr
Operating Income 2.94 Cr36.26 Cr4.23 Cr4.89 Cr2.95 Cr35.71 Cr3.98 Cr7.21 Cr-92.80 L37.31 Cr5.12 Cr2.60 Cr3.45 Cr
EBITDA 3.93 Cr37.02 Cr4.99 Cr5.65 Cr3.93 Cr36.54 Cr4.81 Cr8.04 Cr4.28 Cr40.05 Cr10.10 Cr8.00 Cr8.11 Cr
Interest Expense 1.53 Cr2.76 Cr2.44 Cr2.84 Cr1.07 Cr2.24 Cr2.98 Cr3.90 Cr1.37 Cr3.20 Cr3.66 Cr4.54 Cr4.59 Cr
Pretax Income 1.67 Cr33.62 Cr1.85 Cr4.59 Cr3.24 Cr33.60 Cr1.08 Cr3.79 Cr1.57 Cr35.88 Cr5.46 Cr2.48 Cr2.49 Cr
Tax Provision 23.00 L21.85 L35.00 L77.02 L62.01 L24.86 L-3.00 L1.14 Cr62.73 L65.97 L64.11 L87.28 L2.50 Cr
Net Income 1.43 Cr33.41 Cr1.50 Cr3.82 Cr2.62 Cr33.35 Cr1.11 Cr2.65 Cr1.48 Cr37.28 Cr2.75 Cr1.60 Cr-89,000
Diluted EPS 0.7617.590.792.021.3817.550.581.390.4219.581.400.84-0.79

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 97.00 Cr109.00 Cr-301.36 Cr332.62 Cr364.91 Cr445.10 Cr
Cost of Revenue ---114.61 Cr113.57 Cr135.55 Cr201.50 Cr
Gross Profit ---186.75 Cr219.05 Cr229.36 Cr243.60 Cr
Operating Expenses 82.00 Cr89.00 Cr-140.72 Cr172.22 Cr183.38 Cr195.12 Cr
Operating Income 10.00 Cr15.00 Cr-46.04 Cr46.84 Cr45.98 Cr48.47 Cr
EBITDA 15.00 Cr20.00 Cr-51.76 Cr56.72 Cr54.34 Cr66.26 Cr
Interest Expense 2.00 Cr4.00 Cr-9.57 Cr8.63 Cr10.48 Cr15.99 Cr
Pretax Income 9.00 Cr12.00 Cr-36.16 Cr41.56 Cr40.04 Cr46.30 Cr
Tax Provision -9.00 L48.00 L-1.15 Cr1.95 Cr1.98 Cr4.67 Cr
Net Income 9.00 Cr12.00 Cr-35.01 Cr39.62 Cr38.60 Cr41.63 Cr
Diluted EPS 5.757.34-18.4320.8520.1420.98

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 120.00 Cr158.00 Cr-792.80 Cr880.23 Cr1,026.21 Cr1,097.42 Cr
Current Assets ---519.83 Cr571.66 Cr690.01 Cr778.86 Cr
Cash & Equivalents ---37.99 Cr77.13 Cr88.53 Cr76.00 Cr
Inventory ---207.85 Cr230.31 Cr338.02 Cr450.55 Cr
Receivables ---97.31 Cr94.31 Cr88.90 Cr85.41 Cr
Total Liabilities ---219.62 Cr270.31 Cr381.82 Cr416.96 Cr
Current Liabilities ---216.43 Cr262.45 Cr365.30 Cr394.70 Cr
Long Term Debt ---40.32 L4.87 Cr12.98 Cr17.32 Cr
Total Debt 11.00 Cr19.00 Cr-105.21 Cr110.35 Cr122.50 Cr138.50 Cr
Total Equity 46.00 Cr57.00 Cr-573.17 Cr609.92 Cr644.39 Cr680.46 Cr
Shares Outstanding ---1.90 Cr1.90 Cr1.90 Cr1.90 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow ---38.37 Cr74.59 Cr17.58 Cr-12.57 Cr
Investing Cash Flow ----2.88 Cr-27.40 Cr-3.96 Cr3.46 Cr
Financing Cash Flow ----1.67 Cr-7.78 Cr-2.13 Cr-3.79 Cr
Capital Expenditure ----2.55 Cr-26.78 Cr-7.92 Cr-3.01 Cr
Free Cash Flow ---35.82 Cr47.82 Cr9.66 Cr-15.58 Cr
Net Change in Cash ---33.81 Cr39.41 Cr11.49 Cr-12.90 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ---62.0%65.9%62.9%54.7%
Operating Margin % 10.3%13.8%-15.3%14.1%12.6%10.9%
Net Margin % 9.3%11.0%-11.6%11.9%10.6%9.4%
ROE % 19.6%21.1%-6.1%6.5%6.0%6.1%
ROCE % ---8.0%7.6%7.0%6.9%

Shareholding Pattern

Insiders
61.70%
Institutions
0.00%
Public Float
0.00%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NATHBIOGEN

Google News Sat, 09 Aug 2025

Lacklustre Performance Is Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) 26% Price Drop - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxNeEdfQ2ttb1F1andFenRmejJHNTdZSzNvNmE0YkJSdlZnMUtoM2d1NlE1SjVTTFZwdVdfSHZPdU5LTlM0SzlUUVlWbmt2WDBsZ1Vjc1d1ckEzeVcyWHNYYU1HSVh1a284dDM0ei1aU2ZONTZEV0pBQUZ1aFRGZzY5VFlPTE9qLUxSeVV1TG…

Google News Sat, 29 Jul 2017

NATHBIOGEN Stock Price and Chart — NSE:NATHBIOGEN - TradingView

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1ucnV0SFAtamhTbEFWajl3WXJDNTVuRlNITGVSSlFEZ3ZIaG40QWJ6eUZWZmRVZUtieFpPR0FoMVpyZlhOUllrQjNvd1RfYWc2cFlBSXRHblhyRjhrdkwxZA?oc=5" target="_blank">NATHBIOGEN Stock Price and Chart — NS…

Google News Sun, 03 Aug 2025

Nath Bio-Genes (India) (NSE:NATHBIOGEN) Will Pay A Dividend Of ₹2.00 - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi9AFBVV95cUxQRWxEYjNGS2IwbmV3TldaOUoyQzFGblFqTFQ5YVY5TjQxb0lkeWMyTmR0azF5SGJJM1dMbW1kaXRENzBWalQtTzZNc3Rsck82WC0tUlFadzJNWlo4TkhwSHpFOHFOTTRkVjd2XzJtVlNZSlpaV2lrMERmQmpQMGFRb0dxNVdXc2pDOWVLcF…

Google News Sat, 12 Jul 2025

Nath Bio-Genes (India) Ltd. Share Price Live Today - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNOUp2ZU56MkltQ3B5VHFUSEJkaV9wT1RpXzNEYjE2SnlRZmVyNlI5bHFmSXVETnlJeEp2aXFqWjJPX2MyVDBjcDl1SG9oNTd2NjVnM1ZkUmJZR0dqTy1RNVBadU9sSVUtWG5IeWdpcGxyVXdleFA1enJUazBIUEc4bFhYcHAybG8?oc=5" …

Google News Wed, 09 Jul 2025

We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Can Stay On Top Of Its Debt - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxQd1FUVmpMRWZXX2VjbkNGaEw3UHU1N3dBOFVaU2R1QlFMNFZIak9GV2t3SWNIUjNuRzNLWlJGWHN5Y0RQTUIwaVNqdDBoMWFPXzFwazJyandwdnZBMjZ3UnFVSklxbTFuZHduZTlMM2VpVU1VVnZySmlpeHF3U21HQjNkM3c0aWsyWWFwYk…

Google News Sat, 12 Aug 2017

HARRMALAYA Stock Price and Chart — NSE:HARRMALAYA - TradingView

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE4yR0pJTmxQSDU4YlhWMFJ3SXdFMklJTjdaMTJhZVJmSHVTSWYyVXZYOU1Eby1HdVRkaHJ2bWJqWG9sS1Y0ZWpCek81blVQdVJEX2l3WGpmWFVFRWdWSjE2YQ?oc=5" target="_blank">HARRMALAYA Stock Price and Chart — NS…

NATHBIOGEN — Frequently Asked Questions

What is the current share price of Nath Bio-Genes (India) Limited (NATHBIOGEN)?

As of 2026-07-15 09:52 IST, Nath Bio-Genes (India) Limited (NATHBIOGEN) trades at ₹162.15 on NSE. Its 52-week range is ₹129.02 to ₹227.04.

What is the market capitalisation of NATHBIOGEN?

Nath Bio-Genes (India) Limited (NATHBIOGEN) has a market capitalisation of ₹308.15 Cr on NSE.

What is the P/E ratio of NATHBIOGEN?

NATHBIOGEN trades at a trailing price-to-earnings (P/E) ratio of 7.73. The industry average P/E is 27.45. Its price-to-book (P/B) ratio is 0.54.

Does NATHBIOGEN pay a dividend?

Nath Bio-Genes (India) Limited (NATHBIOGEN) currently offers a dividend yield of 1.21%.

What is the return on equity (ROE) of NATHBIOGEN?

NATHBIOGEN has a return on equity (ROE) of 6.12%. Its return on capital employed (ROCE) is 8.86%.

Is NATHBIOGEN a good stock to buy?

This page provides a data-driven analysis of Nath Bio-Genes (India) Limited (NATHBIOGEN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space